AWM
AGN

Altium Wealth Management’s Allergan plc AGN Stock Holding History

Altium Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,228
Closed -$217K – 348
2020
Q1 		$217K Buy
+1,228
New +$231K 0.03% 284
2018
Q4 		– Sell
-1,703
Closed -$324K – 307
2018
Q3 		$324K Buy
+1,703
New +$313K 0.06% 213

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Altium Wealth Management's AGN Position: Q2 2020 in Review

Altium Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,228 shares — an estimated $217K sold.

Altium Wealth Management first reported a position in AGN in Q3 2018 and held it in 2 quarters. The position peaked at $324K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Altium Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Altium Wealth Management sold 1,228 Allergan plc shares in Q2 2020, an estimated $217K.
  • Altium Wealth Management first reported a position in Allergan plc in Q3 2018 and held it in 2 quarters.
  • Altium Wealth Management's Allergan plc position peaked at $324K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Altium Wealth Management's 13F filing for Q2 2020, filed 31 Jul 2020.